Results 71 to 80 of about 4,911,045 (202)

Parkinsonismo em uma população idosa asilar [PDF]

, 2004
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Pioner, Lucas Mello
core  

‐Induced Dyskinesia

, 2023
BACKGROUND: Current models of levodopa (L-dopa)-induced dyskinesia (LID) are obtained by treating dopamine-depleted animals with L-dopa. However, patients with LID receive combination therapies that often include dopamine agonists.OBJECTIVE: Using 6 ...
Silvia Fanni, Skovgård, Katrine, Katrine Skovgård, Elena Espa, Lu Song, Song, Lu, Fanni, Silvia, Cenci, M Angela, M. Angela Cenci, Espa, Elena   +9 more
core   +1 more source

MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia

EBioMedicine, 2017
In 2009 the U.S. Food and Drug Administration (FDA) placed a black box warning on metoclopramide (MCP) due to the increased risks and prevalence of tardive dyskinesia (TD). In this study, we developed a multi-step biomedical informatics screening (MSBIS)
Dong Xu, Alexandrea G. Ham, Rickey D. Tivis, Matthew L. Caylor, Aoxiang Tao, Steve T. Flynn, Peter J. Economen, Hung K. Dang, Royal W. Johnson, Vaughn L. Culbertson   +9 more
doaj   +1 more source

Fluoxetine Induced Dyskinesia

, 1994
A case of fluoxetine induced dyskinesia in an elderly woman with previous use of low dose haloperidol is described. In contrast to neuroleptic induced tardive dyskinesia it was characterised by a rapid onset after commencing fluoxetine and rapid ...
B. Workman, Michael McCausland, H. Flamer, Alastair Mander, Nicholas Christophidis   +4 more
core   +1 more source

Drug-induced purposeless chewing: animal model of dyskinesia or nausea?

, 1990
Drug-induced purposeless chewing movements in rodents are often considered to represent movement disorders or dyskinesias. We have compared the ability of drugs to induce chewing and retching or emesis in squirrel monkeys; such studies are not possible ...
Tye, SJ, Rupniak, NM, Iversen, SD, Iversen, Susan   +3 more
core   +1 more source

Pallidal versus subthalamic nucleus deep brain stimulation for levodopa‐induced dyskinesia

Annals of Clinical and Translational Neurology, 2020
Objective To compare the efficacy of subthalamic nucleus (STN) and globus pallidus internus (GPi) deep brain stimulation (DBS) on reducing levodopa‐induced dyskinesia (LID) in Parkinson’s disease, and to explore the potential underlying mechanisms ...
Shi‐Ying Fan, Kai‐Liang Wang, Wei Hu, Robert S. Eisinger, Alexander Han, Chun‐Lei Han, Qiao Wang, Shimabukuro Michitomo, Jian‐Guo Zhang, Feng Wang, Adolfo Ramirez‐Zamora, Fan‐Gang Meng   +11 more
doaj   +1 more source

Berberis vulgaris alleviates Levodopa-induced dyskinesia in male mice

Herba Polonica, 2018
Introduction: Parkinson’s disease is a chronic debilitating disease and many patients use Levodopa as a major treatment. However, this drug in long-term use causes a serious condition that is known as Levodopa-induced dyskinesia (LID). Berberis vulgaris (
Mokarian Faezeh, Famitafreshi Hamidreza, Jahromy Mahsa Hadipour   +2 more
doaj   +1 more source

Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats

, 2015
Hongjuan Shi,1,2,* Xinxin Yang,2,3,* Hui Zhao,4 Shenyang Zhang,2 Jie Zu,2 Wei Zhang,2 Xia Shen,2 Guiyun Cui,2,3 Fang Hua,2,3 Chuanzhu Yan1 1Department of Neurology, Qilu Hospital of Shangdong University, Jinan, 2Department of Neurology, Affiliated ...
Yang X, Zhang W, Hua F, Cui G, Yan C, Zhang S, Shen X, Shi H, Zhao H, Zu J   +9 more
core  

Dyskinesia Induced By Phenytoin.

, 2015
Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. To describe the clinical characteristics of phenytoin induced dyskinesia.
Scotoni, A E, Montenegro, M A, Cendes, F
core  

Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study

Brain Sciences, 2019
Background: Safinamide is an approved drug for the treatment of motor fluctuations of Parkinson’s Disease (PD) patients with a potential benefit on non-motor symptoms (NMS).
Gloria Martí-Andrés, Rayco Jiménez-Bolaños, José Matias Arbelo-González, Javier Pagonabarraga, Carmen Duran-Herrera, Rafael Valenti-Azcarate, Mª Rosario Luquin   +6 more
doaj   +1 more source